La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Landfar Bio-medicine Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Changqiao You

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	2.7yrs
Proprietà del CEO	n/a
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	2.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Risks Still Elevated At These Prices As Landfar Bio-medicine Co., Ltd (SZSE:000504) Shares Dive 31%

Jun 09

Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%

Apr 17

Landfar Bio-medicine Co., Ltd (SZSE:000504) Investors Are Less Pessimistic Than Expected

Mar 01

AMMINISTRATORE DELEGATO

Changqiao You (51 yo)

2.7yrs

Mandato

CN¥1,858,800

Compensazione

Mr. Changqiao You is GM & Director of Landfar Bio-medicine Co., Ltd.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Changqiao You	GM & Director	2.7yrs	CN¥1.86m	Nessun dato
Weihua Cu	Independent Director	6yrs	CN¥96.00k	Nessun dato
Yuan Chen	Director	2.7yrs	Nessun dato	Nessun dato
Chen Shen	Supervisor	6yrs	Nessun dato	Nessun dato
Yun Yang	Chairman	2.7yrs	CN¥1.05m	Nessun dato
Haiyi Cao	Director	2.7yrs	Nessun dato	Nessun dato
Yaqing Zhao	Independent Director	2.7yrs	CN¥96.00k	Nessun dato
Ping Zhao	Independent Director	2.7yrs	CN¥96.00k	Nessun dato
Jian Qiu	Chairman of the Supervisory Board	2.7yrs	Nessun dato	Nessun dato
Feng Yan	Employee Representative Supervisor	2.4yrs	Nessun dato	Nessun dato

2.7yrs

Durata media

44.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 000504 non è considerato esperto (durata media del mandato 2.7 anni), il che suggerisce un nuovo consiglio.

Landfar Bio-medicine Gestione

Gestione criteri di controllo 0/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Landfar Bio-medicine Co., Ltd, Annual General Meeting, May 24, 2024

Less than half of directors are independent

NanHua Bio-medicine Co., Ltd, Annual General Meeting, May 25, 2022

Recent updates

Landfar Bio-medicine Co., Ltd to Report First Half, 2024 Results on Aug 31, 2024

Risks Still Elevated At These Prices As Landfar Bio-medicine Co., Ltd (SZSE:000504) Shares Dive 31%

First quarter 2024 earnings released: CN¥0.008 loss per share (vs CN¥0.006 loss in 1Q 2023)

Landfar Bio-medicine Co., Ltd, Annual General Meeting, May 24, 2024

Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%

Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd (SZSE:000504) from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.

Landfar Bio-medicine Co., Ltd to Report Q1, 2024 Results on Apr 30, 2024

Landfar Bio-medicine Co., Ltd (SZSE:000504) Investors Are Less Pessimistic Than Expected

Less than half of directors are independent

Landfar Bio-medicine Co., Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024

Third quarter 2023 earnings released: EPS: CN¥0.033 (vs CN¥0.005 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.023 loss per share (vs CN¥0.007 profit in 2Q 2022)

New minor risk - Share price stability

Now 22% undervalued after recent price drop

Full year 2022 earnings released: CN¥0.04 loss per share (vs CN¥0.06 loss in FY 2021)

Third quarter 2022 earnings released: CN¥0.005 loss per share (vs CN¥0.007 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.007 (vs CN¥0.023 loss in 2Q 2021)

NanHua Bio-medicine Co., Ltd, Annual General Meeting, May 25, 2022

First quarter 2022 earnings released: EPS: CN¥0.001 (vs CN¥0.003 in 1Q 2021)

Third quarter 2021 earnings released: CN¥0.007 loss per share (vs CN¥0.004 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.023 loss per share (vs CN¥0.002 loss in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.005 loss in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.03 (vs CN¥0.06 in FY 2019)

NanHua Bio-medicine Co., Ltd to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day high: CN¥13.58

New 90-day low: CN¥9.82

New 90-day low: CN¥12.15

New 90-day low: CN¥12.42

NanHua Bio-medicine Co., Ltd to Report Q3, 2020 Results on Oct 26, 2020

New 90-day high - CN¥14.24

NanHua Bio-medicine Co., Ltd to Report First Half, 2020 Results on Aug 28, 2020